What the name refers to
A biocompatible mineral used in particular dermal-filler and medical-device products, with approval tied to the finished product.
Evidence and regulatory context
The broad ingredient name is not enough to determine approval. Regulatory status belongs to the exact finished product, formulation, intended use and jurisdiction.
Reading product records
Authorisation often belongs to a particular branded formulation, device, indication and professional setting—not to a broad ingredient name. Records should emphasise manufacturer, market-specific approval, batch, cold-chain or storage requirements and supply-chain provenance.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.